These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23754915)

  • 21. Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease).
    Miteff F; Potter HC; Allen J; Teoh H; Roxburgh R; Hutchinson DO
    J Clin Neurosci; 2011 Aug; 18(8):1055-8. PubMed ID: 21658951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Case Report of McArdle Disease Diagnosed Following Statin-Induced Myositis.
    Teles JS; Ramos CT; Almeida BM; Sousa AV
    Cureus; 2023 Sep; 15(9):e44701. PubMed ID: 37809236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genes and exercise intolerance: insights from McArdle disease.
    Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
    Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. McArdle Disease Misdiagnosed as Meningitis.
    Scalco RS; Chatfield S; Junejo MH; Booth S; Pattni J; Godfrey R; Quinlivan R
    Am J Case Rep; 2016 Nov; 17():905-908. PubMed ID: 27899787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A first in literature: anesthesia management in kidney transplant surgery of a patient with McArdle disease.
    Bicak EA
    Niger J Clin Pract; 2023 Jul; 26(7):1045-1049. PubMed ID: 37635594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
    Quinlivan R; Martinuzzi A; Schoser B
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD003458. PubMed ID: 25391139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).
    Quinlivan R; Beynon RJ; Martinuzzi A
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003458. PubMed ID: 18425888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
    Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
    Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac comorbidities in McArdle disease: case report and systematic review.
    Hoxhaj D; Vadi G; Bianchi L; Fontanelli L; Torri F; Siciliano G; Ricci G
    Neurol Sci; 2024 May; ():. PubMed ID: 38802689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. McArdle disease: 2 case reports.
    Diez Morrondo C; Pantoja Zarza L; San Millán Tejado B
    Reumatol Clin; 2016; 12(3):161-3. PubMed ID: 26235145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McArdle Disease: Clinical, Biochemical, Histological and Molecular Genetic Analysis of 60 Patients.
    Joshi PR; Deschauer M; Zierz S
    Biomedicines; 2020 Feb; 8(2):. PubMed ID: 32075227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
    Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
    Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRES leading to the diagnosis of McArdle disease.
    Martinez-Thompson JM; Pittock SJ; Milone M
    J Clin Neurosci; 2017 Dec; 46():62-64. PubMed ID: 28887083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
    Lorenzoni PJ; Werneck LC; Kay CSK; Arndt RC; Silvado CES; Scola RH
    Acta Neurol Belg; 2020 Apr; 120(2):303-311. PubMed ID: 30415384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [McArdle disease: report of four brothers with myophosphorylase deficiency].
    López Martín A; Baños Madrid RI; García-Estañ Candela J; García Pérez B; Pérez Bautista FJ; Salmerón P
    An Med Interna; 2001 Mar; 18(3):136-8. PubMed ID: 11594178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
    Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute renal failure due to rhabdomyolysis in a child with McArdle disease.
    Delibaş A; Bek K; Ezgü FS; Demircin G; Oksal A; Oner A
    Eur J Pediatr; 2008 Aug; 167(8):939-40. PubMed ID: 17899190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
    Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
    Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can a modified ketogenic diet be a nutritional strategy for patients with McArdle disease? Results from a randomized, single-blind, placebo-controlled, cross-over study.
    Løkken N; Nielsen MR; Stemmerik MG; Ellerton C; Revsbech KL; Macrae M; Slipsager A; Krett B; Beha GH; Emanuelsson F; van Hall G; Quinlivan R; Vissing J
    Clin Nutr; 2023 Nov; 42(11):2124-2137. PubMed ID: 37769369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
    de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.